S.C. Ropharma S.A. (BVB:RPH)

S.C. Ropharma Income Statement

Financials in millions RON. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Operating Revenue	1,324	1,191	1,006	912.74	776.69	716.27
Other Revenue	143.79	132.11	113.83	89.23	111.47	89.58
Revenue	1,468	1,323	1,120	1,002	888.16	805.85
Revenue Growth (YoY)	16.96%	18.12%	11.80%	12.81%	10.21%	2.83%
Cost of Revenue	1,153	1,030	866.05	788.1	686.93	625.55
Gross Profit	315.18	292.79	254.14	213.88	201.23	180.31
Selling, General & Admin	224.36	210.7	184.61	156.95	142.62	124.74
Other Operating Expenses	32.59	29.03	22.86	23.88	18.34	22.32
Operating Expenses	287.65	268.37	234.12	204.62	184.12	169.75
Operating Income	27.53	24.42	20.02	9.26	17.11	10.55
Interest Expense	-5.39	-5.86	-5.56	-3.44	-3.21	-3.26
Interest & Investment Income	0.08	0.08	0.08	0.03	0.24	0.03
Currency Exchange Gain (Loss)	-3.33	-0.33	-2.08	-0.25	-2.43	-2.35
Other Non Operating Income (Expenses)	0.31	0.43	0.46	0.75	0.27	-0
EBT Excluding Unusual Items	19.19	18.73	12.91	6.35	11.99	4.97
Gain (Loss) on Sale of Assets	0.43	0.93	0.18	2.81	0.95	0.03
Asset Writedown	4.77	1.89	0.6	1.16	0.6	1.64
Pretax Income	24.38	21.55	13.69	10.32	13.53	6.64
Income Tax Expense	15.1	16.17	2.01	2.82	1.96	2
Earnings From Continuing Operations	9.28	5.38	11.68	7.49	11.57	4.64
Minority Interest in Earnings	-5.82	-7.1	-3.96	1.72	-0.84	2.12
Net Income	3.46	-1.73	7.72	9.22	10.73	6.75
Net Income to Common	3.46	-1.73	7.72	9.22	10.73	6.75
Net Income Growth	-	-	-16.25%	-14.10%	58.86%	-10.23%
Shares Outstanding (Basic)	509	511	511	511	511	510
Shares Outstanding (Diluted)	509	511	511	511	511	510
Shares Change (YoY)	-0.89%	-	-	-	0.30%	-0.00%
EPS (Basic)	0.01	-0.00	0.02	0.02	0.02	0.01
EPS (Diluted)	0.01	-0.00	0.02	0.02	0.02	0.01
EPS Growth	-	-	-16.25%	-14.11%	58.38%	-10.22%
Free Cash Flow	38.11	32.29	26.9	11.88	21.53	-20.68
Free Cash Flow Per Share	0.07	0.06	0.05	0.02	0.04	-0.04
Gross Margin	21.47%	22.13%	22.69%	21.35%	22.66%	22.38%
Operating Margin	1.88%	1.85%	1.79%	0.92%	1.93%	1.31%
Profit Margin	0.24%	-0.13%	0.69%	0.92%	1.21%	0.84%
Free Cash Flow Margin	2.60%	2.44%	2.40%	1.19%	2.42%	-2.57%
EBITDA	45.64	41.19	36.2	24.18	31.36	25.2
EBITDA Margin	3.11%	3.11%	3.23%	2.41%	3.53%	3.13%
D&A For EBITDA	18.11	16.77	16.18	14.92	14.25	14.65
EBIT	27.53	24.42	20.02	9.26	17.11	10.55
EBIT Margin	1.88%	1.85%	1.79%	0.92%	1.93%	1.31%
Effective Tax Rate	61.93%	75.04%	14.69%	27.38%	14.48%	30.15%
Revenue as Reported	1,475	1,327	1,122	1,005	890.27	810.89

Source: S&P Global Market Intelligence. Standard template. Financial Sources.